Model N Announces Date of Third Quarter Fiscal Year 2019 Financial Results

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), a leading provider of cloud revenue management solutions for life sciences and high tech companies, plans to announce financial results for the third quarter fiscal year 2019 after market close on Tuesday, August 6, 2019. The company also will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to review its financial results and business outlook.

The conference call can be accessed by dialing (877) 407-4018 from the United States or (201) 689-8471 internationally with reference to the company name and conference title. A live webcast and replay of the conference call can be accessed from the investor relations page of Model N’s website at investor.modeln.com. Following the completion of the call through 11:59 p.m. ET on August 13, 2019, a telephone replay will be available by dialing (844) 512-2921 from the United States or (412) 317-6671 internationally with recording access code 13692261.

About Model N

Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Driving mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives, our software helps companies know and grow their true top line and maximize every revenue moment at speed and scale. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Contacts

Investor Relations Contact:

ICR for Model N

Staci Mortenson, 650-610-4998

investorrelations@modeln.com

Media Contact:

pr@modeln.com

Staff

Recent Posts

Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE:…

36 minutes ago

Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion

NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers…

8 hours ago

Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025

LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY),…

11 hours ago

GREATER MIAMI JEWISH FEDERATION RELEASES JEWISH MIAMI: A 2024 COMMUNITY STUDY

DEMOGRAPHIC FINDINGS SHOW CONTINUED GROWTH, TREMENDOUS DIVERSITY AND DEEP CONNECTIONS TO ISRAEL AND JEWISH LIFE…

11 hours ago

Shapiro+Raj Expands Team with Strategic Hires to Accelerate Life Sciences Growth

CHICAGO, April 7, 2025 /PRNewswire/ -- Shapiro+Raj, the #1 Strategic and #12 Most Innovative Insights…

11 hours ago

CAS and Cleveland Clinic collaborate to accelerate research through advanced AI and quantum computing

COLUMBUS, Ohio, April 7, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society…

11 hours ago